SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-17-005595
Filing Date
2017-05-22
Accepted
2017-05-22 06:23:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D sc13d0417a4canfite_ophtha.htm SC 13D/A 60477
  Complete submission text file 0001213900-17-005595.txt   62147
Mailing Address 10 BAREKET STREET PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET PETACH TIKVA L3 4951778 972 3 9241114
OphthaliX, Inc. (Subject) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82946 | Film No.: 17859627
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filed by) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations